NYSE: AGE - AgeX Therapeutics, Inc.

Altı ay boyunca karlılık: 0%
Temettü getirisi: 0.00%
Sektör: Healthcare

Promosyon programı AgeX Therapeutics, Inc.

Gelişmiş program Basit grafik
Financial Markets by TradingView

Şirket hakkında AgeX Therapeutics, Inc.

AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-related metabolic disorders, such as Type II adult-onset diabetes and obesity; and AGEX-VASC1, a cell-based therapy to restore vascular support in aged ischemic tissues, such as peripheral vascular disease and ischemic heart disease.

daha fazla ayrıntı
Its lead small molecule drug-based therapeutic candidate for scarless wound repair in discovery is AGEX-iTR1547, a drug-based formulation; and lead biologic candidate for induced tissue regeneration is AGEX-iTR1550 (Renelon), a gene delivery technology. AgeX Therapeutics, Inc. has a research collaboration with the University of California at Irvine to develop cellular therapies to treat neurological disorders and diseases. The company was incorporated in 2017 and is based in Alameda, California.
Karşılaştırma listesine ekle
İzleme listesine ekle
Portföye ekle
Fiyat bildirimi ekle

IPO date 2018-11-29
ISIN US00848H1086
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.agexinc.com
Цена ао 11.1
Günlük fiyat değişimi: 0% (11.1)
Haftalık fiyat değişimi: 0% (11.1)
Aylık fiyat değişimi: 0% (11.1)
3 ayda fiyat değişimi: 0% (11.1)
Altı ayda fiyat değişimi: 0% (11.1)
Yıllık fiyat değişimi: -50.27% (22.32)
3 yılda fiyat değişimi: +1 508.7% (0.69)
5 yılda fiyat değişimi: +692.86% (1.4)
10 yılda fiyat değişimi: 0% (11.1)
Yılbaşından bu yana fiyat değişimi: 0% (11.1)
Tüm parametreler

Hafife alma

İsim Anlam Seviye
P/S 2.98 6
P/BV 0.079 10
P/E 0 0
EV/EBITDA -0.4521 0
Toplam: 5.13

Yeterlik

İsim Anlam Seviye
ROA, % -123.72 0
ROE, % -270.67 0
Toplam: 0

Temettüler

İsim Anlam Seviye
Div yield, % 0 0
DSI 0 0
Toplam: 0

Görev

İsim Anlam Seviye
Debt/EBITDA -0.4441 10
Toplam: 10

Büyüme dürtüsü

İsim Anlam Seviye
karlılık Revenue, % -91.65 0
karlılık Ebitda, % -15.27 0
karlılık EPS, % 4028.55 10
Toplam: 2.6
Daha fazla ayrıntı

Kurumlar Hacim Paylaşmak, %
Broadwood Capital, Inc. 2997156 7.9
Vanguard Group Inc 701755 1.85
Sigma Planning Corp 286425 0.75
Prescott General Partners LLC 185185 0.49
Bridgeway Capital Management, Inc. 144770 0.38
Geode Capital Management, LLC 140994 0.37
Blackrock Inc. 124301 0.33
Strategic Wealth Investment Group, LLC 97375 0.26
Creative Planning 70700 0.19
Northern Trust Corporation 31533 0.08

ETFPaylaşmak, %Yıllık karlılık, %Temettüler, %
Sprott Uranium Miners ETF 0.42828 343.52 3.27507
Global X Uranium ETF 0.21695 7.84 1.74266
0.33175.682.51



Süpervizör İş unvanı Ödeme Doğum yılı
Ms. Eun-Jae Park CPA Chief Financial Officer 295.29k 1972 (53 yıl)
Dr. Ivan Labat Chief Information Officer N/A
Ms. Judith Segall Secretary N/A 1953 (72 yıl)

Adres: United States, Alameda. CA, 1101 Marina Village Parkway - Google haritalarda aç, Yandex haritalarını aç
Web sitesi: https://www.agexinc.com